Skip to main content
. 2019 Jun 6;137(9):1054–1058. doi: 10.1001/jamaophthalmol.2019.1493

Table. Clinical and Genetic Characteristics of the Only-Unilateral Familial Exudative Vitreoretinopathy in This Cohort.

Patient No./Gestational Age, wk/Birth Weight, g Age at Presentation Affected Eye Family History Initial Diagnosis Visual Acuity Clinical Presentation Disease Stage Gene Mutation Type Minor Allele Frequency In Silico Analysis Score
SIFT Poly-Phen 2 Mutation-Taster GERP++
1/40/3250 2 y OD Positive FEVR LP Temporal retinal fold 4A LRP5 c.1801G>A; p.G601Ra Missense mutation NA D Pd Dc C
2/39/3450 6 y OS Negative PFVS NLP Total RD 5B LRP5 c.3361A>G; p.N1121Da Missense mutation 0.003 T B Dc C
3/38/3300 2 y OS Negative FEVR NLP Total RD 5B LRP5 c.G3977A;p.R1326Ha Missense mutation NA T B P C
4/37/3100 2 mo OD Negative PFVS NLP Total RD 5B LRP5 c.266A>G;p.Q89R Missense mutation 0.003 T B Dc C
5/40/3150 4 y OS Negative FEVR FC/BE Temporal retinal fold 4B LRP5 c.2872C>T;p.R958Wa Missense mutation NA D Pd Dc C
6/38/3000 2 y OS Positive RD NA ERD; flat AC 5A LRP5 c.1969A>G;p.R657Ga Missense mutation NA D B Dc NC
7/40/3600 1 y OD Negative RD NA ERD 5B LRP5 c.920C>A;p.S307Ya Missense mutation NA D Pd Dc C
8/39/3200 7 y OD Positive Toxocariasis 0.6 Nasal drag disc 3B LRP5 c.1193G>A;p.R398Ha Missense mutation NA D Pd Dc C
9/40/3450 2 y OD Negative Coats Temporal retinal fold; exudate 3B LRP5 c.290C>T;p.A97Va Missense mutation 0.0008 T B P NC
10/39/3300 5 mo OS Positive RD NA Total RD 5B LRP5 c.893G>A;p.R298Ha Missense mutation 0.0008 T B P NC
11/39/3600 3 mo OD Negative FEVR LP Temporal retinal fold 4B LRP5 c.C290T;p.A97Va Missense mutation 0.0008 T B P NC
12/39/3600 8 mo OD Positive PFVS NA Total RD 5B FZD4 c.217-234del;p.73-78dela Deletion mutation NA NA NA NA NA
13/40/3400 1 y OS Positive PFVS LP Total RD 5B FZD4 c.747dupC;p.Y250fsa Frameshift mutation NA NA NA NA NA
14/39/3800 7 mo OS Negative FEVR FC/BE Temporal retinal fold; exudate 4B FZD4 c.686T>C; p.L229Pa Missense mutation NA NA NA NA NA
15/38/3400 11 y OD Negative Maculopathy 0.25 Peripheral vascular abnormalities and macular exudation 1B FZD4 c.C205T;p.H69Y Missense mutation 0.0002 D B Dc C
16/39/3200 4 y OS Positive PFVS NLP Total RD 5A ZNF408 c.1083delG;p.K361fsa Frameshift mutation NA NA NA NA NA
17/40/3450 2 y OS Positive PFVS HM Temporal retinal fold 4B ZNF408 c.2125G>A;p.E709Ka Missense mutation NA D B Dc C
18/38/3300 2 y OS Positive RD NLP Total RD 5B NDP c.258G>T;p.K86Na Missense mutation NA D Pd Dc C
19/40/3500 2 y OS Negative PFVS NLP Total RD 5B TSPAN12 c.715A>T; p.I239Fa Missense mutation NA T B Dc C
20/40/4300 1 y OS Negative RD NLP Total RD 5B TSPAN12 c.*44C>T;/ NA 0.0002 NA NA NA NA

Abbreviations: AC, anterior chamber; B, benign; BE, before eye; C, conserved; D, damaging; Dc, disease-causing, ERD, exudative retinal detachment; FC, figure counting; FEVR, familial exudative vitreoretinopathy; GERP ++, genomic evolutionary rate profiling; HM, hand moving; LP, light perception; NA, none available; NC, nonconserved; NLP, no light perception; Pd; probably damaging; PFVS, persistent fetal vasculature syndrome; RD, retinal detachment; SIFT, sorting intolerant from tolerant; T, tolerated.

a

The mutation site is novel that has not been reported in patients with FEVR.